title: Coronary artery disease. Are β-blockers truly helpful in patients with CAD?
abstract: In a large, new, observational study, β-blocker treatment did not improve clinical outcomes in patients with coronary artery disease (CAD), including those with previous myocardial infarction, and was associated with more events in individuals with risk factors only. The role of β-blockers for secondary prevention in these patients should be reconsidered.
authors.affiliation: Department of Cardiology, Hôpital Européen Georges Pompidou, 20 rue Leblanc, Paris, France. nicolasdanchin@yahoo.fr
authors.forename: Nicolas
authors.initials: N
authors.lastname: Danchin
authors.forename: Stéphane
authors.initials: S
authors.lastname: Laurent
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000188:drug therapy*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D012307:Risk Factors; D055502:Secondary Prevention / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D002317:Cardiovascular Agents